Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study.

Avanzo A, Salomone F, Di Maio M, D'Ambrosio S, Vitale F, Viggiano A, Liguori L, Isernia MC, Russo A, Longo L, Napolitano F, Santaniello A, Formisano L, Bianco R, Servetto A.

Open source

DOI
10.1016/j.critrevonc.2025.104952
Published
2025-09-18
Container
Crit Rev Oncol Hematol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.critrevonc.2025.104952,
  title = {Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study.},
  author = {Avanzo A and  Salomone F and  Di Maio M and  D'Ambrosio S and  Vitale F and  Viggiano A and  Liguori L and  Isernia MC and  Russo A and  Longo L and  Napolitano F and  Santaniello A and  Formisano L and  Bianco R and  Servetto A.},
  year = {2025},
  journal = {Crit Rev Oncol Hematol},
  doi = {10.1016/j.critrevonc.2025.104952},
  url = {https://doi.org/10.1016/j.critrevonc.2025.104952}
}

RIS

TY  - JOUR
TI  - Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study.
AU  - Avanzo A
AU  -  Salomone F
AU  -  Di Maio M
AU  -  D'Ambrosio S
AU  -  Vitale F
AU  -  Viggiano A
AU  -  Liguori L
AU  -  Isernia MC
AU  -  Russo A
AU  -  Longo L
AU  -  Napolitano F
AU  -  Santaniello A
AU  -  Formisano L
AU  -  Bianco R
AU  -  Servetto A.
PY  - 2025
JO  - Crit Rev Oncol Hematol
DO  - 10.1016/j.critrevonc.2025.104952
UR  - https://doi.org/10.1016/j.critrevonc.2025.104952
ER  - 

APA

A, A., F, S., M, D. M., S, D., F, V., A, V., L, L., MC, I., A, R., L, L., F, N., A, S., L, F., R, B., & A., S. (2025). Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research study.. Crit Rev Oncol Hematol. https://doi.org/10.1016/j.critrevonc.2025.104952

Source records